These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31211959)

  • 1. Flow-mediated dilation shows impaired endothelial function in patients with mastocytosis.
    Bucci T; Parente R; De Feo G; Cardamone C; Triggiani M
    J Allergy Clin Immunol; 2019 Oct; 144(4):1106-1111. PubMed ID: 31211959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
    Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
    J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
    Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
    J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease spectrum in patients with elevated serum tryptase levels.
    Aberer E; Savic S; Bretterklieber A; Reiter H; Berghold A; Aberer W
    Australas J Dermatol; 2015 Feb; 56(1):7-13. PubMed ID: 24575854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
    Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M
    Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired endothelial function irrespective of systemic inflammation or atherosclerosis in mastocytosis.
    Öztop N; Özer PK; Demir S; Beyaz Ş; Tiryaki TO; Özkan G; Aydogan M; Bugra MZ; Çolakoglu B; Büyüköztürk S; Nalçacı M; Yavuz AS; Gelincik A
    Ann Allergy Asthma Immunol; 2021 Jul; 127(1):76-82. PubMed ID: 33775901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress markers are increased in patients with mastocytosis.
    Gangemi S; Minciullo PL; Magliacane D; Saitta S; Loffredo S; Saija A; Cristani M; Marone G; Triggiani M
    Allergy; 2015 Apr; 70(4):436-42. PubMed ID: 25630934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
    Schwartz LB
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
    Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.
    Gülen T; Hägglund H; Dahlén B; Nilsson G
    J Intern Med; 2016 Mar; 279(3):211-28. PubMed ID: 26347286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.
    Theoharides TC; Boucher W; Spear K
    Int Arch Allergy Immunol; 2002 Aug; 128(4):344-50. PubMed ID: 12218373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast-cell phenotype in indolent forms of mastocytosis. Ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase, tryptase, and carboxypeptidase.
    Weidner N; Horan RF; Austen KF
    Am J Pathol; 1992 Apr; 140(4):847-57. PubMed ID: 1562049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.
    Lee SJ; Lee DW; Kim KS; Lee IK
    Diabetes Res Clin Pract; 2001 Dec; 54 Suppl 2():S81-92. PubMed ID: 11733113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of heterogenity in endothelium-dependent vasodilatation occurrence in healthy individuals with or without coronary risk factors].
    Polovina M; Potpara T; Giga V; Ostojić M
    Vojnosanit Pregl; 2009 Oct; 66(10):813-20. PubMed ID: 19938760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis.
    Kurosawa M; Amano H; Kanbe N; Akimoto S; Takeuchi Y; Yamashita T; Hashimoto T; Kurimoto F; Miyachi Y
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S25-32. PubMed ID: 9440541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
    Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
    Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
    Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
    Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
    J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
    Greiner G; Sprinzl B; Górska A; Ratzinger F; Gurbisz M; Witzeneder N; Schmetterer KG; Gisslinger B; Uyanik G; Hadzijusufovic E; Esterbauer H; Gleixner KV; Krauth MT; Pfeilstöcker M; Keil F; Gisslinger H; Nedoszytko B; Niedoszytko M; Sperr WR; Valent P; Hoermann G
    Blood; 2021 Jan; 137(2):238-247. PubMed ID: 32777817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.